ĐẶT LỊCH KHÁM

On February 14, 2025, the Andrology and Fertility Hospital of Hanoi had the honor of welcoming the Merck Healthcare delegation. Merck Healthcare is a global leader in the pharmaceutical industry and a long-standing international strategic partner of the hospital. This visit not only reinforces the strong relationship between...

First Trimester Prenatal Screening (11th- 13th Week) This is a crucial stage to detect genetic abnormalities at the earliest. Common screening methods include: Ultrasound: Evaluates the structure of the fetus, particularly measuring the nuchal translucency to detect the risk of heart defects or genetic syndromes. Blood...

Preimplantation Genetic Testing for Aneuploidy (PGT-A) is an advanced genetic testing method that helps identify abnormalities in the number and structure of chromosomes (chromosomal abnormalities) in embryos. Performed during in vitro fertilization (IVF) treatment, PGT-A helps genetic experts screen for healthy embryos...

Genetic Abnormalities in Male Infertility Infertility has become a global issue, with an increasing rate in both men and women. This issue, especially in men, cannot be overlooked. According to a report by the World Health Organization (WHO), 1 in 6 people worldwide experiences infertility, with 50% of the causes attributed...

Genetic testing plays a crucial role in assisted reproductive treatment as it helps couples identify and address genetic abnormalities early, thereby increasing the chances of having a healthy and safe pregnancy. With modern medical foundations and technological advancements, the close relationship between genetics and...

Parental Age and Its Impact on the Fetus Women over the age of 35 and men over the age of 50 have a higher risk of giving birth to a child with congenital disabilities. This is due to the decline in the quality of eggs and sperm, which increases the likelihood of chromosomal division errors […]

Currently, up to 90% of Down syndrome cases can be detected while the fetus is still in the womb through advanced screening methods. Screening for this condition requires coordination of several factors such as maternal age, ultrasound measurement of nuchal translucency and Down syndrome markers, and blood tests for biological...

Spinal Muscular Atrophy (SMA) is a rare autosomal recessive neurological-muscular disorder. The cause of SMA is a homozygous or compound heterozygous mutations in the SMN1 gene, which results in insufficient production of the SMN protein necessary for nerve-muscle communication. Individuals who are heterozygous carriers...